BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8547135)

  • 1. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
    Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
    Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
    Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
    Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of AML1-MTG8 transcript by reverse transcriptase polymerase chain reaction in a patient in remission of acute myeloid leukemia (M2) after low-dose cytosine arabinoside.
    Sawada H; Serino Y; Wake A; Yamasaki Y; Izumi Y
    Leuk Res; 1998 Sep; 22(9):853-7. PubMed ID: 9716019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
    Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
    Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
    Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
    EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL; Chan V; Wong KF; Chan TK
    Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
    Nucifora G; Rowley JD
    Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.
    Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
    J Cancer Res Clin Oncol; 1996; 122(4):254-6. PubMed ID: 8601580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21).
    Tobal K; Yin JA
    Blood; 1996 Nov; 88(10):3704-9. PubMed ID: 8916934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
    Krauter J; Wattjes MP; Nagel S; Heidenreich O; Krug U; Kafert S; Bunjes D; Bergmann L; Ganser A; Heil G
    Br J Haematol; 1999 Oct; 107(1):80-5. PubMed ID: 10520027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission.
    Guerrasio A; Rosso C; Martinelli G; Lo Coco F; Pampinella M; Santoro A; Lanza C; Allione B; Resegotti L; Saglio G
    Br J Haematol; 1995 Jun; 90(2):364-8. PubMed ID: 7794758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
    Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
    Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse.
    Tobal K; Newton J; Macheta M; Chang J; Morgenstern G; Evans PA; Morgan G; Lucas GS; Liu Yin JA
    Blood; 2000 Feb; 95(3):815-9. PubMed ID: 10648391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
    Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
    Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
    Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
    Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
    Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
    Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.